XML 56 R46.htm IDEA: XBRL DOCUMENT
v3.21.1

STOCK OPTIONS (Tables) | 9 Months Ended
--- | ---
Mar. 31, 2021
Fair value weighted average assumptions |
| Nine Months Ended March 31, |
| 2021 |  |  | 2020 |
Expected volatility |  | 45.38% to 81.97% |  |  |  | 45.38% to 65.49% |
Risk-free interest rate |  | 0.14% to 2.35% |  |  |  | 0.30% to 2.35% |
Expected life (years) |  | 0.25 -4.51 |  |  |  | 2.5-3.25 |
2017 Employee Plan |
Option activities | A summary of option activities under the 2017 Employee Plan during the nine months period ended March 31, 2021 is presented as follows:
|  | Options |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Term (Years) |  |  | Aggregate Intrinsic Value |
Outstanding at July 1, 2020 |  |  | 196,000 |  |  | $ | 3.92 |  |  |  | 3.72 |  |  | $ | 36.00 |
Granted |  |  | 71,000 |  |  |  | 5.03 |  |  |  | - |  |  |  | - |
Exercised |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Forfeited or expired |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Outstanding at March 31, 2021 |  |  | 267,000 |  |  | $ | 4.21 |  |  |  | 3.47 |  |  | $ | 210.40 |
Exercisable at March 31, 2021 |  |  | 149,750 |  |  | $ | 4.46 |  |  |  | 2.99 |  |  | $ | 106.07 |
A summary of option activities under the 2017 Employee Plan during the nine months period ended March 31, 2020 is presented as follows:
|  | Options |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Term (Years) |  |  | Aggregate Intrinsic Value |
Outstanding at July 1, 2019 |  |  | 136,000 |  |  | $ | 4.53 |  |  |  | 4.28 |  |  | $ | - |
Granted |  |  | 60,000 |  |  |  | 2.53 |  |  |  | 4.98 |  |  |  | - |
Exercised |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Forfeited or expired |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Outstanding at March 31, 2020 |  |  | 196,000 |  |  | $ | 3.91 |  |  |  | 3.97 |  |  | $ | 9.6 |
Exercisable at March 31, 2020 |  |  | 83,000 |  |  | $ | 4.65 |  |  |  | 3.60 |  |  | $ | 2.4 |
Company's non-vested employee stock options | A summary of the status of the Company’s non-vested employee stock options during the nine months ended March 31, 2021 is presented below:
|  | Options |  |  | Weighted Average Grant-Date Fair Value |
Non-vested at July 1, 2020 |  |  | 98,000 |  |  | $ | 3.39 |
Granted |  |  | 71,000 |  |  |  | - |
Vested |  |  | (51,750 | ) |  |  | - |
Forfeited |  |  | - |  |  |  | - |
Non-vested at March 31, 2021 |  |  | 117,250 |  |  | $ | 3.90 |
A summary of the status of the Company’s non-vested employee stock options during the nine months ended March 31, 2020 is presented below:
|  | Options |  |  | Weighted Average Grant-Date Fair Value |
Non-vested at July 1, 2019 |  |  | 87,000 |  |  | $ | 4.28 |
Granted |  |  | 60,000 |  |  |  | 2.53 |
Vested |  |  | (34,000 | ) |  |  | 4.19 |
Forfeited |  |  | - |  |  |  | - |
Non-vested at March 31, 2020 |  |  | 113,000 |  |  | $ | 3.37 |
2007 Employee Plan |
Option activities | A summary of option activities under the 2007 Employee Plan during the nine months ended March 31, 2021 is presented as follows:
|  | Options |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Term (Years) |  |  | Aggregate Intrinsic Value |
Outstanding at July 1, 2020 |  |  | 77,500 |  |  | $ | 3.69 |  |  |  | 1.22 |  |  | $ | - |
Granted |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Exercised |  |  | (40,000 | ) |  |  | 3.26 |  |  |  | - |  |  |  | - |
Forfeited or expired |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Outstanding at March 31, 2021 |  |  | 37,500 |  |  | $ | 4.14 |  |  |  | 0.99 |  |  | $ | 13.13 |
Exercisable at March 31, 2021 |  |  | 37,500 |  |  | $ | 4.14 |  |  |  | 0.99 |  |  | $ | 13.13 |
A summary of the status of the Company’s non-vested employee stock options under the 2007 Employee Plan during the nine months ended March 31, 2020 is presented below:
|  | Options |  |  | Weighted Average Grant-Date Fair Value |
Non-vested at July 1, 2019 |  |  | 9,375 |  |  | $ | 4.14 |
Granted |  |  | - |  |  |  | - |
Vested |  |  | (9,375 | ) |  |  | - |
Forfeited |  |  | - |  |  |  | - |
Non-vested at March 31, 2020 |  |  | - |  |  | $ | - |
Company's non-vested employee stock options |
|  | Options |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Term (Years) |  |  | Aggregate Intrinsic Value |
Outstanding at July 1, 2019 |  |  | 77,500 |  |  | $ | 3.69 |  |  |  | 2.22 |  |  | $ | - |
Granted |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Exercised |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Forfeited or expired |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Outstanding at March 31, 2020 |  |  | 77,500 |  |  |  | 3.69 |  |  |  | 1.46 |  |  |  | - |
Exercisable at March 31, 2020 |  |  | 77,500 |  |  | $ | 3.69 |  |  |  | 1.46 |  |  | $ | - |
Directors 2017 Equity Incentive Plan |
Option activities | A summary of option activities under the 2017 Directors Plan during the nine months ended March 31, 2021 is presented as follows:
|  | Options |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Term (Years) |  |  | Aggregate Intrinsic Value |
Outstanding at July 1, 2020 |  |  | 240,000 |  |  | $ | 3.93 |  |  |  | 3.75 |  |  | $ | 48.00 |
Granted |  |  | 80,000 |  |  |  | 5.27 |  |  |  | 4.89 |  |  |  | - |
Exercised |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Forfeited or expired |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Outstanding at March 31, 2021 |  |  | 320,000 |  |  | $ | 4.27 |  |  |  | 3.47 |  |  | $ | 253.6 |
Exercisable at March 31, 2021 |  |  | 320,000 |  |  | $ | 4.27 |  |  |  | 3.47 |  |  | $ | 253.6 |
A summary of option activities under the 2017 Directors Plan during the nine months ended March 31, 2020 is presented as follows:
|  | Options |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Term (Years) |  |  | Aggregate Intrinsic Value |
Outstanding at July 1, 2019 |  |  | 160,000 |  |  | $ | 4.63 |  |  |  | 4.25 |  |  | $ | - |
Granted |  |  | 80,000 |  |  |  | 2.53 |  |  |  | 4.98 |  |  |  | - |
Exercised |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Forfeited or expired |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Outstanding at March 31, 2020 |  |  | 240,000 |  |  | $ | 3.93 |  |  |  | 4.00 |  |  | $ | 12.80 |
Exercisable at March 31, 2020 |  |  | 240,000 |  |  | $ | 3.93 |  |  |  | 4.00 |  |  | $ | 12.80 |
2007 Directors Equity Incentive Plan |
Option activities | A summary of option activities under the 2007 Directors Plan during the nine months ended March 31, 2021 is presented as follows:
|  | Options |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Term (Years) |  |  | Aggregate Intrinsic Value |
Outstanding at July 1, 2020 |  |  | 250,000 |  |  | $ | 3.32 |  |  |  | 0.83 |  |  | $ | 22.00 |
Granted |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Exercised |  |  | (200,000 | ) |  |  | 3.12 |  |  |  | - |  |  |  | - |
Forfeited or expired |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Outstanding at March 31, 2021 |  |  | 50,000 |  |  | $ | 4.14 |  |  |  | 0.99 |  |  | $ | 17.50 |
Exercisable at March 31, 2021 |  |  | 50,000 |  |  | $ | 4.14 |  |  |  | 0.99 |  |  | $ | 17.50 |
A summary of option activities under the 2007 Directors Plan during the six months ended March 31, 2020 is presented as follows:
|  | Options |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Term (Years) |  |  | Aggregate Intrinsic Value |
Outstanding at July 1, 2019 |  |  | 300,000 |  |  | $ | 3.40 |  |  |  | 1.58 |  |  | $ | 9.50 |
Granted |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Exercised |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Forfeited or expired |  |  | (50,000 | ) |  |  | (3.81 | ) |  |  | - |  |  |  | - |
Outstanding at March 31, 2020 |  |  | 250,000 |  |  |  | 3.32 |  |  |  | 1.08 |  |  |  | - |
Exercisable at March 31, 2020 |  |  | 250,000 |  |  | $ | 3.32 |  |  |  | 1.08 |  |  | $ | - |

X
- Definition Tabular disclosure of all information related to the key inputs and assumptions (including, at a minimum, but not limited to, and if applicable, quantitative information about discount rates, expected prepayments including the expected weighted-average life of prepayable financial assets, and anticipated credit losses) used in measuring the fair value of assets or liabilities that relate to the transferor's continuing involvement with transferred financial assets, as of the balance sheet date. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 860 -SubTopic 20 -Section 50 -Paragraph 4 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719 + Details
Name: | us-gaap_ScheduleOfAssumptionsForFairValueAsOfBalanceSheetDateOfInterestsContinuedToBeHeldByTransferorServicingAssetsOrServicingLiabilitiesTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the details pertaining to each employee stock ownership plan. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 40 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=109244661&loc=d3e17540-113929 + Details
Name: | us-gaap_ScheduleOfEmployeeStockOwnershipPlanESOPDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_PlanNameAxis=TRT_EmployeePlan2017Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_PlanNameAxis=TRT_EmployeePlan2007Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_PlanNameAxis=TRT_Directors2017EquityIncentivePlanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_PlanNameAxis=TRT_DirectorsEquityIncentivePlanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |